BriaCell Therapeutics Corp. (BCT.TO)

CAD 0.87

(-4.4%)

Total Debt Summary of BriaCell Therapeutics Corp.

  • BriaCell Therapeutics Corp.'s latest annual total debt in 2024 was - USD , down 0.0% from previous year.
  • BriaCell Therapeutics Corp.'s latest quarterly total debt in 2024 Q4 was - USD , down 0.0% from previous quarter.
  • BriaCell Therapeutics Corp. reported annual total debt of - USD in 2023, down 0.0% from previous year.
  • BriaCell Therapeutics Corp. reported annual total debt of - USD in 2022, down -100.0% from previous year.
  • BriaCell Therapeutics Corp. reported quarterly total debt of - USD for 2024 Q1, down 0.0% from previous quarter.
  • BriaCell Therapeutics Corp. reported quarterly total debt of - USD for 2024 Q3, down 0.0% from previous quarter.

Annual Total Debt Chart of BriaCell Therapeutics Corp. (2024 - 2006)

Historical Annual Total Debt of BriaCell Therapeutics Corp. (2024 - 2006)

Year Total Debt Total Debt Growth
2024 - USD 0.0%
2023 - USD 0.0%
2022 - USD -100.0%
2021 25.98 Thousand USD -88.64%
2020 228.74 Thousand CAD -24.09%
2019 301.32 Thousand CAD -73.11%
2018 1.12 Million CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%

Peer Total Debt Comparison of BriaCell Therapeutics Corp.

Name Total Debt Total Debt Difference
Appili Therapeutics Inc. 8.18 Million CAD 100.0%
Eupraxia Pharmaceuticals Inc. 13.78 Million CAD 100.0%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 6.64 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. 423 Thousand CAD 100.0%
Sernova Corp. 136.12 Thousand CAD 100.0%